Bell, K. M., Plon, L., Bunney, W. E., & Potkin, S. G. (1988). S-adenosylmethionine treatment of depression: A controlled clinical trial. American Journal of Psycbiatry, 145, 1110-1114.
2.
Bottiglieri, T., Laundy, M., Martin, R., Carney, M. W., Nissenbaum, H., Toone, B. K., Johnson A. L., & Reynolds, E.H. (1984). S-adenosylmethionine increases monoamine metabolism. Lancet, 2, 224-224.
3.
Carney, M. W., Chary, T. K., Bottiglieri, T., & Reynolds, E. H. (1989). The switch mechanism and the bipolar/unipolar dichotomy. Britisb Journal of Psychiatry, 154, 48-51.
4.
Carney, M. W., Edeh, J., Bottiglieri, T., Reynolds, E. M., & Toone, B. K. (1986). Affective illness and s-adenosylmethionine: A preliminary report. Clinical Neuropharmacology, 9, 379-385.
5.
Cowley, G. (1999, March 22). The "Sammy" solution. Newsweek, 64-68.
6.
Cowley, G., & Underwood, A. (1999, July 5). What is SAMe?Newsweek, 32-33.
7.
Deltito, J., & Beyer, D. (1998). The scientific, quasi-scientific and popular literature on St. John's wort in the treatment of depression. Journal of Affective Disorders, 51, 345-351.
8.
Dimpfel, W., Todorova, A., & Vonderheid-Guth, B. (1999). Pharmacodynamic properties of St. John's wort-A single blind neurophysiological study in healthy subjects comparing two commercial preparations. European Journal of Medical Research, 4, 303-312.
9.
Ernst, E., Rand, J. I., Barnes, J., & Stevinson, C. (1998). Adverse effects profile of the herbal antidepressant St. John's wort. European Journal of Clinical Pharmacology, 54, 589-594.
10.
Fava, M., Giannelli, A., Rapisarda, V., Patralia, A., & Guaraldi, G. P. (1995). Rapidity of onset of the antidepressant effect of parenteral S-adenosyl-L-methionine. Psychiatric Research, 56, 295-297.
11.
Franklin, M., Chi, J., McGavin, C., Hockney, R., Reed, A., Campling, G., Whale, R. W., & Cowan, P. J. (1999). Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers. Biological Psychiatry, 46, 581-584.
12.
Harrer, G., Schmidt, U., Kuhn, U., & Biller, A. (1999). Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine. Arzneimittelforschung, 49, 289-296.
13.
Hippius, H. (1998). St. John's wort-A herbal antidepressant. Current Medical Research Opinions, 14, 171-184.
14.
Kagan, B. L., Sultzer, D. L., Rosenlicht, N., & Gerner, R. H. (1990). Oral s-adenosylmethionine in depression: A randomized, double blind, placebo-controlled trial. American Journal of Psychiathy, 147, 591-595.
15.
Lantz, M. S., Buchalter, E., & Giambanco, V. (1999). St. John's wort and antidepressant drug interactions in the elderly. journal of Geriatric Psychiatry and Neurology, 12 (1), 7-10.
16.
Linde, K., Ramirez, G., Mulrow, C. D., Pauls, A., Weidenhammer, W., & Melchart, D. (1996). St. John's wort for depression-An overview and meta analysis of randomized clinical trials. British Medical Journal, 313, 253-258.
17.
Murray, M. (1996). SAMe. In: Encyclopedia of nutritional supplements. Rockling, CA: Prima Publishing.
18.
Rodriguez, N. (1999). Herbal remedies. Health Net, 1(2), 3-3.
19.
Sharpley, A. L., McGavin, C. L., Whale, R., & Cowen, P. J. (1998). Antidepressant-like effect of hypericum perforatum (St. John's wort) on the sleep polysomnogram. Psychopharmacology, 139, 286-287.
20.
Singer, A., Wonnemann, M., & Muller, W. E. (1999). Hyperforin, a major constituent of St. John's wort, inhibits serotonin uptake by elevating free intracellular sodium. Journal of Pharmacology and Evperimental Therapeutics, 290, 1363-1368.
21.
Sommer, H., & Harrer, G. (1994). Placebo controlled double blind study examining the effectiveness of a hypericum preparation in 105 mildly depressed patients. Journal of Geriatric Psychiatry and Neurology, 7 (Suppl. 1), 9-11.
22.
Vorbach, E. U., Hubner, W. D., & Arnoldt, K. H. (1994). Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: Randomized double blind study with 135 outpatients. Journal of Geriatric Psychiatry and Neurology, 7 (Suppl. 1), 19-23.
